Melatonin long term safety
Pro Research Analysisby 
Searched over 200M research papers
Melatonin Long-Term Safety: Overview and Key Findings
Long-Term Safety Data and Research Gaps
There is a general lack of comprehensive long-term safety data for melatonin, especially for use beyond six months in both adults and children. Most studies agree that while short-term use appears safe, the long-term effects, particularly in special populations such as children, pregnant or lactating women, and those with psychiatric or organic diseases, remain insufficiently studied and understood Arendt1997Besag2022Andersen2016.
Safety in Children and Adolescents
Several studies have examined melatonin's long-term use in children, especially those with neurodevelopmental disorders or chronic insomnia. These studies consistently report that melatonin is effective for improving sleep onset and quality, with no serious adverse events or treatment-related comorbidities observed over periods ranging from several months to years Hoebert2009De Leersnyder2011Mantle2020+1 MORE. Non-serious side effects, such as mild sleepiness, are more common, but serious adverse events are rare Händel2023Hydzik2020.
Concerns about potential impacts on pubertal development have been raised, but most studies found little or no influence after 2–4 years of treatment. One study noted a possible delay in puberty after more than seven years of use, but the evidence is limited and requires further investigation Pacheco2024Händel2023Mantle2020. Effects on bone health and other long-term developmental outcomes are still uncertain and need more research .
Safety in Adults
For healthy adults, long-term melatonin use (at typical doses) has not been associated with serious adverse effects. Mild side effects such as dizziness, headache, nausea, and sleepiness have been reported, but these are generally comparable to placebo Arendt1997Pacheco2024Andersen2016. There is a lack of data on long-term use in adults with underlying health conditions or those taking other medications, and interactions with other drugs are not well studied Arendt1997Andersen2016.
Special Populations and Precautions
Melatonin should be used with caution in pregnant or breastfeeding women, as there is insufficient evidence regarding safety in these groups Arendt1997Andersen2016. Similarly, individuals with psychiatric disorders or those on multiple medications should consult healthcare providers before using melatonin long-term due to unknown risks .
Recommendations and Monitoring
Routine medical monitoring is recommended for anyone using melatonin long-term, especially children. Establishing the correct dosage and monitoring for adverse events is important to ensure safety Pacheco2024Händel2023. Some experts suggest periodic discontinuation of melatonin, particularly in children, to reassess the need for ongoing treatment and to monitor for any changes in circadian rhythms or development .
Conclusion
Current evidence suggests that melatonin is generally safe for long-term use in both children and adults, with most adverse events being mild and non-serious. However, significant gaps remain in our understanding of its long-term safety, especially regarding pubertal development, bone health, and use in special populations. Ongoing medical supervision and further research are needed to fully establish the long-term safety profile of melatonin Pacheco2024Besag2022Händel2023+1 MORE.
Sources and full results
Most relevant research papers on this topic